Vertical transmission of maternal COVID-19 antibodies after CoronaVac vaccine: A case report

The use of coronavirus disease 2019 RNA vaccines in pregnant women led to reports on the first cases of newborns with antibodies to sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a phenomenon that was unknown when using immunizations with inactivated viruses. Thus, this study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Menegali, Bruno Thizon, Schuelter-Trevisol, Fabiana, Barbosa, Alexandre Naime, Izidoro, Talita Menegali, Feurschuette, Otto Henrique May, Marcon, Chaiana Esmeraldino Mendes, Trevisol, Daisson José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Medicina Tropical - SBMT 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582956/
https://www.ncbi.nlm.nih.gov/pubmed/34787263
http://dx.doi.org/10.1590/0037-8682-0385-2021
Descripción
Sumario:The use of coronavirus disease 2019 RNA vaccines in pregnant women led to reports on the first cases of newborns with antibodies to sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a phenomenon that was unknown when using immunizations with inactivated viruses. Thus, this study aimed to report a case of passive anti-SARS-CoV-2 immunity in a newborn through immunoprophylaxis of a pregnant woman who received the CoronaVac® vaccine in the third trimester of pregnancy. Twenty-four hours after delivery, samples were collected from the newborn and screened by enzyme immunoassays, which revealed antibodies to SARS-CoV-2.

Ejemplares similares